Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
- 1 November 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 14 (11) , 1687-1694
- https://doi.org/10.1161/01.atv.14.11.1687
Abstract
The genetic basis of familial combined hyperlipidemia (FCHL) has eluded investigators for 20 years, despite the apparent segregation of FCHL as an autosomal dominant disorder affecting 1% to 2% of individuals. Etiologic heterogeneity and additive effects of traits controlled by other genetic loci have been suggested. Two traits have been implicated in FCHL. The first is the predominance of a small, dense low-density lipoprotein (LDL), LDL subclass phenotype B, which segregates as a mendelian trait. The second is a mendelian locus with large effects on apolipoprotein (apo) B levels that is defined by complex segregation analysis (predicted apoB level genotype). This study shows that these factors appear to be separate genetic effects, both of which aid in the prediction of FCHL in four large pedigrees. The results suggest that FCHL may be best predicted by a threshold model in which apoB level genotype and LDL subclass phenotype each act to increase the risk of FCHL. Heterogeneity in the transmission of apoB levels among families is suggested, supporting the etiologic heterogeneity of FCHL. These results emphasize the advantages inherent in the study of large pedigrees when disease heterogeneity is suspected.Keywords
This publication has 43 references indexed in Scilit:
- Genetics of low-density lipoprotein subclassesCurrent Opinion in Lipidology, 1993
- Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemiaAtherosclerosis, 1992
- Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liverJournal of Inherited Metabolic Disease, 1990
- Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemiaAtherosclerosis, 1990
- Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.Journal of Clinical Investigation, 1990
- Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart diseaseAtherosclerosis, 1988
- Apolipoprotein B–Gene DNA Polymorphisms Associated with Myocardial InfarctionNew England Journal of Medicine, 1986
- A mixed-model likelihood approximation on large pedigreesComputers and Biomedical Research, 1982
- A General Transmission Probability Model for Pedigree DataHuman Heredity, 1981
- THE DETECTION OF LINKAGE WITH RECESSIVE ABNORMALITIESAnnals of Eugenics, 1935